Table 1. Patient characteristics (n = 20; female/male = 12/8).
| Patient characteristics | Mean (SD) | Range |
|---|---|---|
| Demographics | ||
| Age (years) | 58 (10) | 41–74 |
| Body surface area (m2) | 1.73 (0.19) | 1.37–2.25 |
| Weight (kg) | 65 (13) | 45–106 |
| Laboratory measurements | ||
| Alanine aminotransferase (IU l−1) | 31 (30) | 12–127 |
| Aspartate aminotransferase (IU l−1) | 40 (39) | 9–178 |
| Alkaline phosphatase (IU l−1) | 137 (98) | 40–407 |
| γ-Glutamyl transpeptidase (IU l−1) | 156 (279) | 15–1174 |
| Bilirubinaemia (µm) | 8.7 (3.8) | 4.7–16.6 |
| Serum α1-acid glycoprotein (g l−1) | 1.2 (0.7) | 0.5–3.2 |
| Albuminaemia (g l−1) | 36 (5) | 25–42 |
| Serum creatinine (µm) | 73 (14) | 55–104 |
| Lymphocyte count (µl−1) | 921 (353) | 132–1500 |
| Platelet count (× 103 µl−1) | 283 (88) | 163–493 |
| Disease and treatment | ||
| WHO performance status* (0/1/2) | 7/10/3 | |
| Vinorelbine dose (mg/m2) | 25 (9) | 20–30 |
| Tumour type: breast/oesophagus/CUP†/lung/others | 6/5/3/2/4 | |
| Liver metastasis (yes/no) | 8/12 | |
*
World Health Organization performance status: 0, fully active; 1, restricted in physically strenuous activity but ambulatory; 2, ambulatory and capable of all selfcare but unable to carry out any work activities.
†
Carcinoma of unknown primary.